Michael Handke

Prof. Dr. med.

Dirk Nonhoff

Dr. med.

Terje Johannessen

professor i allmennmedisin

Liv Gøtzsche

overlæge dr. med

--&gt; http://dx.doi.org/10.3238/arztebl.2011.0372

Trappe HJ, Gummert J. Current pacemaker and defibrillator therapy. Dtsch Arztebl Int 2011; 108: 372-380. doi:10.3238/arztebl.2011.0372

--&gt; http://dx.doi.org/10.1093/europace/euu153

Martens E, Sinner M, Siebermair J, et al. Incidence of sudden cardiac death in Germany: results from an emergency medical service registry in Lower Saxony. Europace 2014; 16: 1752-1758. doi:10.1093/europace/euu153

Seidl K, Senges J. Worldwide utilization of implantable cardioverter/defibrillators now and in the future. Card Electrophysiol Rev 2003; 7: 5-13.

Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98: 2334-51.

--&gt; http://dx.doi.org/10.1093/eurheartj/ehv316

Priori S, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015; 36: 2793-2867. doi:10.1093/eurheartj/ehv316

--&gt; http://dx.doi.org/10.1007/s12181-016-0115-z

Deneke T, Borggrefe M, Hindricks G. Kommentar zu den ESC-Leitlinien 2015 „Ventrikuläre Arrhythmien und Prävention des plötzlichen Herztodes“. Kardiologe 2017; 11: 27-43. doi:10.1007/s12181-016-0115-z

Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001; 345: 1473-82.

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=Ann N Y Acad Sci [ta]+AND+382[vol]+AND+3[page]

Kannel WB, Thomas HE Jr. Sudden coronary death: the Framingham Study. Ann N Y Acad Sci 1982; 382: 3-21.

Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992; 85(1 suppl): I2-I10.

Hohnloser SH, Kuck KH, Dorian P, et al.; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481-8.

Bardy GH, Lee KL, Mark DB, et al.; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.

Ezekowitz JA, Rowe BH, Dryden DM, et al. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 2007; 147: 251-62.

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=N Engl J Med [ta]+AND+303[vol]+AND+322[page]

Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303:322.

--&gt; http://dx.doi.org/10.1056/NEJM199711273372202

The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337: 1576 – 1583. doi:10.1056/NEJM199711273372202

--&gt; http://dx.doi.org/10.1161/01.CIR.101.11.1297

Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297–1302. doi:10.1161/01.CIR.101.11.1297

Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102: 748 – 754. doi10.1161/01.CIR.102.7.748

--&gt; http://dx.doi.org/10.1053/euhj.2000.2476

Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000;21:2071–2078. doi:10.1053/euhj.2000.2476

--&gt; http://dx.doi.org/10.1056/NEJMoa013474

Moss AJ, Zareba W, Hall WJ, et al.: The Multicenter Automatic Defibrillator Implantation Trial II Investigators: prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–83.doi:10.1056/NEJMoa013474

--&gt; http://dx.doi.org/10.1056/NEJMoa043399

Bardy GH, Lee KL, Mark DB: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225–37. doi:10.1056/NEJMoa043399

--&gt; http://dx.doi.org/10.1056/NEJMoa033088

Kadish A, Dyer A, Daubert JP, et al. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151–2158. doi:10.1056/NEJMoa033088

--&gt; http://dx.doi.org/10.1001/jama.292.23.2874

Desai AS, Fang JC, Maisel WH, et al. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 2004;292:2874 – 2879. doi:10.1001/jama.292.23.2874

--&gt; http://dx.doi.org/10.1093/eurheartj/eht150

Brignole M, Angelo Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2013; 34: 2281-2329. doi:10.1093/eurheartj/eht150

--&gt; http://dx.doi.org/10.1093/eurheartj/ehv292

Bänsch D, Bonnemeier H, Brandt J, et al. Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial. Eur Heart J 2015; 36: 2500-2507. doi:10.1093/eurheartj/ehv292

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=Pacing Clin Electrophysiol [ta]+AND+28[vol]+AND+926[page]

Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005; 28: 926-32.

Journal of the American Medical Association

--&gt; http://jama.ama-assn.org/cgi/search?volume=296&amp;firstpage=2839

Gehi AK, Mehta D, Gomes JA. Evaluation and management of patients after implantable cardioverter-defibrillator shock. JAMA 2006; 296: 2839-47.

--&gt; http://dx.doi.org/10.1016/j.hrthm.2015.02.035

van der Heijden A, Borleffs C, Buiten M, et al. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.. Heart Rhythm 2015; 12: 1169-1176. doi:10.1016/j.hrthm.2015.02.035

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=Arch Gen Psychiatry [ta]+AND+65[vol]+AND+1324[page]

Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry 2008; 65: 1324-30.

--&gt; http://dx.doi.org/10.1007/s12181-011-0331-5

Ginzburg D, Tavenaux M, Sperzel J, et al. Psychische Störungen nach ICD-Mehrfachschocks und deren psychotherapeutische Behandlung. Kardiologe 2011; 5: 114-121. doi:10.1007/s12181-011-0331-5

--&gt; https://leitlinien.dgk.org/2010/empfehlungen-zum-einsatz-von-elektrokautern-bei-patienten-mit-herzschrittmachern-und-implantierten-defibrillatoren/

Nowak B, Israel C, Willems S, et al. Empfehlungen zum Einsatz von Elektrokautern bei Patienten mit Herzschrittmachern und implantierten Defibrillatoren. Kardiologe 2010; 4: 383-388.

Naehle CP, Strach K, Thomas D, et al. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2009; 54: 549-55.

--&gt; http://dx.doi.org/10.3238/arztebl.2012.0270

Bovenschulte H, Schlüter-Brust K, Liebig T. MRI in patients with pacemakers—overview and procedural management.. Dtsch Arztebl Int 2012; 109: 270-75. doi:10.3238/arztebl.2012.0270

--&gt; http://dx.doi.org/10.1007/s12181-017-0124-6

Sommer T, Bauer W, Fischbach K, et al. MR-Untersuchungen bei Patienten mit Herzschrittmachern und implantierbaren Kardioverter-Defibrillatoren. Kardiologe 2017; 11: 97. doi:10.1007/s12181-017-0124-6

--&gt; http://dx.doi.org/10.1007/s12181-010-0308-9

Klein H, Krämer A, Pieske B, et al. Fahreignung bei kardiovaskulären Erkrankungen. Kardiologe 2010; 4: 441-473. doi:10.1007/s12181-010-0308-9

F. Hartel et al. Leitlinien zum Fahrverbot bei ICD-Patienten: Anspruch und Realität. Clin Res Cardiol 103, Suppl 1, April 2014. P1775 der 80. Jahrestagung der Deutschen Gesellschaft für Kardiologie (DGK)

--&gt; http://dx.doi.org/10.3238/arztebl.2012.0535

Carlsson J, Paul N, Dann M, et al. The deactivation of implantable cardioverter-defibrillators:medical, ethical, practical, and legal considerations. Dtsch Arztebl Int 2012; 109: 535-541. doi:10.3238/arztebl.2012.0535

Implantierbarer Kardioverter-Defibrillator

Ventrikuläre Rhythmusstörungen und plötzlicher Herztod

Häufigkeit

Ätiologie und Pathogenese

Diagnostik bei V. a. ventrikuläre Arrhythmien bzw. dokumentierten ventrikulären Arrhythmien

Prädisponierende Faktoren

Indikationen zur ICD-Implantation

Sekundärprävention von plötzlichem Herztod

Primärprävention von plötzlichem Herztod

ICD-Therapie

Allgemeines zur Therapie

Therapieformen und Nachsorge

Komplikationen

Nichtkardiale Operationen

MRT-Untersuchungen

Fahrerlaubnis

Vorgehen am Lebensende

Patienteninformationen

Patienteninformationen in Deximed

Illustrationen

Quellen

Leitlinien

Literatur

Autor*innen